Private Healthcare Market Report 2026

The private healthcare market size has grown strongly in recent years. It will grow from $5.39 trillion in 2025 to $5.68 trillion in 2026 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to growth of private health insurance coverage, increasing preference for faster medical access, expansion of specialty healthcare services, rising medical tourism activity, improved availability of private healthcare facilities.

The private healthcare market size is expected to see strong growth in the next few years. It will grow to $6.92 trillion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increasing integration of digital health technologies, rising demand for personalized medicine offerings, expansion of premium healthcare services, growing investments in private hospital infrastructure, increasing focus on value-based care models. Major trends in the forecast period include expansion of personalized private healthcare services, rising adoption of digital health platforms, growing demand for preventive and wellness care, increasing use of advanced diagnostics, enhanced focus on patient experience and convenience.

The rising prevalence of lifestyle-related disorders is expected to drive growth in the private healthcare market in the coming years. Lifestyle-related disorders are conditions that develop primarily from daily habits and choices, including poor diet, lack of exercise, stress, and harmful addictions. These disorders are increasing due to urbanization and sedentary lifestyles, where long working hours and reduced physical activity contribute to negative health outcomes. Private healthcare supports the management of lifestyle-related disorders by offering faster access to specialized doctors and personalized treatment plans, enabling early intervention and better long-term outcomes. For example, in May 2024, the British Diabetic Association (Diabetes UK), a UK-based patient, healthcare professional, and research charity, reported that approximately 4.4 million people in the UK were living with a diabetes diagnosis in 2022-23. Of these, around 8% have type 1 diabetes, 90% have type 2 diabetes, and the remaining 2% include less common types. Consequently, the growing incidence of lifestyle-related disorders is driving the private healthcare market.

Leading companies in the private healthcare sector are focusing on advanced solutions such as agentic AI to improve clinical decision-making, automate administrative tasks, and deliver personalized patient care while ensuring data privacy and regulatory compliance. Agentic AI refers to artificial intelligence capable of making independent decisions and taking autonomous actions. For instance, in April 2025, OneAdvanced, a UK-based provider of sector-focused SaaS software, launched a private large language model (LLM) designed for healthcare organizations. The platform enables secure, role-based AI applications while safeguarding sensitive patient data. OneAdvanced’s private LLM offers a fully encrypted, closed AI environment, sector-specific intelligence, retrieval-augmented generation, and agentic AI to enhance decision-making and automation. Customizable workspaces allow secure team collaboration while maintaining regulatory compliance.

In December 2024, Reliance Industries Ltd., an India-based private sector company, acquired Karkinos Healthcare for $0.045 billion. Through this acquisition, Reliance Industries aims to strengthen its healthcare presence, expand its oncology diagnostics and treatment portfolio, and leverage Karkinos Healthcare’s advanced cancer care technologies to provide affordable and accessible solutions across India. Karkinos Healthcare is an India-based provider of private healthcare services.

Major companies operating in the private healthcare market are HCA Healthcare, Fresenius Medical Care, Tenet Healthcare Corporation, Universal Health Services, Ramsay Health Care, Mediclinic International, Bupa, Apollo Hospitals, Manipal Hospitals, Thumbay Hospital, Spire Healthcare Group Plc, One Medical, Fortis Healthcare Limited, BMI Healthcare, Circle Health Group, Saudi German Health, The London Clinic Ltd., Pantai Holdings, Aspen Healthcare, Parkway Pantai Ltd., IHH Healthcare Berhad, NMC Healthcare.

North America was the largest region in the private healthcare market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the private healthcare market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the private healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the private healthcare market by increasing costs of imported medical devices, diagnostic equipment, surgical instruments, and advanced healthcare technologies. Private hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported medical systems, while Asia-Pacific faces higher capital expenditure for facility upgrades. These tariffs are increasing treatment costs and capital investment requirements. However, they are also encouraging domestic medical device manufacturing, regional supplier development, and greater adoption of cost-optimized healthcare technologies.

The private healthcare market research report is one of a series of new reports that provides private healthcare market statistics, including private healthcare industry global market size, regional shares, competitors with a private healthcare market share, detailed private healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the private healthcare industry. This private healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Private healthcare is a system of medical care organized and financed by entities outside government control, such as individuals, corporations, or private organizations. Rather than relying primarily on public funding, it is supported through out-of-pocket payments, insurance plans, or corporate contributions. This system operates independently of state-run facilities and is often associated with faster access, a broader range of patient options, and a focus on comfort and quality in healthcare delivery.

The main types of private healthcare services include primary care, specialty care, diagnostic services, surgical procedures, and wellness services. Primary care encompasses basic health services provided by general physicians or family doctors. Services also reflect consumer preferences such as complementary medicine and personalized medicine and are applied across areas including trauma and orthopedics, general surgery, oncology, maternity and obstetrics-gynecology, cardiology, and urology. End users include international patients, private medical insurance referrals, insured individuals, and self-paying patients.

The private healthcare market includes revenues earned by entities by providing services such as laboratory testing, childcare services, rehabilitation, and mental health services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.